Episode

MONEY BALL Episode 2 - Robert Boyce, Plakous Therapeutics

Podcast
The Healthy Enterprise
Published
Jan 2, 2026
Duration seconds
1679
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/bc6ebfdb
Audio
https://media.transistor.fm/bc6ebfdb/5e3d3331.mp3
JSON
/v1/public/podcasts/the-healthy-enterprise-7243627/episodes/money-ball-episode-2-robert-boyce-plakous-therapeutics
Markdown
/podcast/the-healthy-enterprise-7243627/money-ball-episode-2-robert-boyce-plakous-therapeutics.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-healthy-enterprise-7243627/episodes/money-ball-episode-2-robert-boyce-plakous-therapeutics/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-healthy-enterprise-7243627/money-ball-episode-2-robert-boyce-plakous-therapeutics.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences. In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC. Chapters: 00:00 Introduction to Plakous Therapeutics 01:08 Understanding Necrotizing Enterocolitis (NEC) 04:23 The Genesis of Plakous Therapeutics 06:24 Innovative Approach to Treatment 09:27 Real-Life Impact: Case Study of Laurel 13:32 Navigating the Funding Landscape 16:06 Refining the Pitch Process 22:05 Challenges in the Current Investment Climate 25:11 Current Stage and Future Plans Guest Information: Guest's Name: Robert Boyce Guest's Title/Position: Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/robertwboyce/ Company / Affiliation: Plakous Therapeutics https://www.plakoustherapeutics.com/ Guest's Bio: Rob Boyce is the CEO of Plakous Therapeutics , Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his…